FDA Advisory Committee Recommends Pfizer Covid-19 Vaccine for Children Aged 5 to 11
Pfizer has submitted data from clinical trials involving lower doses of its Covid-19 vaccine and children aged 5 to 11. Because the clinical trials were successful and vaccinated children had a robust immune response, the pharmaceutical company sent the results…